CCRN icon

Cross Country Healthcare

14.87 USD
-0.02
0.13%
Updated Apr 1, 2:59 PM EDT
1 day
-0.13%
5 days
-0.87%
1 month
-12.94%
3 months
-18.16%
6 months
13.51%
Year to date
-18.16%
1 year
-19.36%
5 years
105.39%
10 years
21.99%
 

About: Cross Country Healthcare Inc is a provider of total talent management services, including strategic workforce solutions, contingent staffing, permanent placement, and consultative services for healthcare customers. The company operates in two business segments: the nurse and allied staffing segment, which generates a vast majority of revenue, offers temporary and permanent placements of travel and local nurses and allied professionals, and other outsourcing services.: the Physician Staffing segment provides licensed practitioners across a broad array of specialties, as well as certified registered nurse anesthetists (CRNAs), nurse practitioners (NPs), and physician assistants (PAs) on temporary assignments. The company earns majority of its revenue from the United States.

Employees: 2,300

0
Funds holding %
of 7,398 funds
Analysts bullish %

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

56% more call options, than puts

Call options by funds: $239K | Put options by funds: $153K

22% more capital invested

Capital invested by funds: $470M [Q3] → $574M (+$104M) [Q4]

4% less funds holding

Funds holding: 179 [Q3] → 172 (-7) [Q4]

4.78% less ownership

Funds ownership: 102.7% [Q3] → 97.92% (-4.78%) [Q4]

11% less first-time investments, than exits

New positions opened: 50 | Existing positions closed: 56

41% less repeat investments, than reductions

Existing positions increased: 39 | Existing positions reduced: 66

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

Low target
$18.61
25%
upside
Avg. target
$18.61
25%
upside
High target
$18.61
25%
upside

1 analyst rating

positive
0%
neutral
100%
negative
0%
Barrington Research
Kevin Steinke
28% 1-year accuracy
19 / 67 met price target
25%upside
$18.61
Market Perform
Maintained
14 Mar 2025

Financial journalist opinion

Based on 5 articles about CCRN published over the past 30 days

Positive
Zacks Investment Research
3 weeks ago
Are Investors Undervaluing Cross Country Healthcare (CCRN) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Are Investors Undervaluing Cross Country Healthcare (CCRN) Right Now?
Positive
Zacks Investment Research
3 weeks ago
Cross Country (CCRN) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
The headline numbers for Cross Country (CCRN) give insight into how the company performed in the quarter ended December 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Cross Country (CCRN) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
Negative
Zacks Investment Research
3 weeks ago
Cross Country Healthcare (CCRN) Misses Q4 Earnings Estimates
Cross Country Healthcare (CCRN) came out with quarterly earnings of $0.04 per share, missing the Zacks Consensus Estimate of $0.11 per share. This compares to earnings of $0.29 per share a year ago.
Cross Country Healthcare (CCRN) Misses Q4 Earnings Estimates
Neutral
Business Wire
3 weeks ago
Cross Country Healthcare Announces Fourth Quarter and Full Year 2024 Financial Results
BOCA RATON, Fla.--(BUSINESS WIRE)--Cross Country Healthcare, Inc. (the “Company”) (Nasdaq: CCRN) today announced financial results for its fourth quarter and full year ended December 31, 2024. SELECTED FINANCIAL INFORMATION: Dollars are in thousands, except per share amounts Q4 2024 Variance Q4 2024 vs Q4 2023 Variance Q4 2024 vs Q3 2024 Full Year 2024   Variance 2024 vs 2023 Revenue $ 309,940       (25 ) %   (2 ) % $ 1,344,004       (33 ) % Gross profit margin*   20.0   %   (190 ) bps   (40 ).
Cross Country Healthcare Announces Fourth Quarter and Full Year 2024 Financial Results
Neutral
Zacks Investment Research
3 weeks ago
5 Broker-Loved Stocks to Keep an Eye on Amid Trade Tensions
Investors should monitor stocks like Cardinal Health, DXC Technology, Cross Country Healthcare, Avnet and Asbury for high returns.
5 Broker-Loved Stocks to Keep an Eye on Amid Trade Tensions
Neutral
Business Wire
1 month ago
Cross Country Healthcare Stockholders Approve Aya Healthcare Transaction
BOCA RATON, Fla.--(BUSINESS WIRE)--Cross Country Healthcare, Inc. (“Cross Country” or the “Company”) (NASDAQ: CCRN) today announced that the Company has obtained all requisite stockholder approvals in connection with its proposed acquisition by Aya Healthcare. As previously disclosed, Cross Country and Aya Healthcare expect to complete the transaction in the second half of 2025, subject to the satisfaction or waiver of customary closing conditions specified in the Merger Agreement. Upon complet.
Cross Country Healthcare Stockholders Approve Aya Healthcare Transaction
Positive
Zacks Investment Research
1 month ago
3 Staffing Stocks to Consider Despite Industry Challenges
The Zacks Staffing Firms industry is hindered by the manufacturing sector's economic downturn. However, HSII, CCRN and HQI are likely to be the leading entities to witness steady service demand, and the rising adoption of remote work and technology.
3 Staffing Stocks to Consider Despite Industry Challenges
Neutral
Business Wire
2 months ago
CROSS COUNTRY HEALTHCARE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Cross Country Healthcare, Inc. - CCRN
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Cross Country Healthcare, Inc. (NasdaqGS: CCRN) to Aya Healthcare. Under the terms of the proposed transaction, shareholders of Cross Country will receive $18.61 in cash for each share of Cross Country that they own. KSF is seeking to determine whether this consideration and the process that led to it are adeq.
CROSS COUNTRY HEALTHCARE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Cross Country Healthcare, Inc. - CCRN
Neutral
Business Wire
2 months ago
CCRN Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Cross Country Healthcare, Inc. Is Fair to Shareholders
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Cross Country Healthcare, Inc. (NASDAQ: CCRN) to Aya Healthcare for $18.61 per share in cash is fair to Cross Country shareholders. Halper Sadeh encourages Cross Country shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or sadeh@halpersadeh.com or zhalper@halpersadeh.com. The investigation concerns.
CCRN Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Cross Country Healthcare, Inc. Is Fair to Shareholders
Neutral
Business Wire
3 months ago
CROSS COUNTRY HEALTHCARE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Cross Country Healthcare, Inc. - CCRN
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Cross Country Healthcare, Inc. (NasdaqGS: CCRN) to Aya Healthcare. Under the terms of the proposed transaction, shareholders of Cross Country will receive $18.61 in cash for each share of Cross Country that they own. KSF is seeking to determine whether this consideration and the process that led to it are adeq.
CROSS COUNTRY HEALTHCARE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Cross Country Healthcare, Inc. - CCRN
Charts implemented using Lightweight Charts™